Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Gross Profit (2019 - 2025)

Historic Gross Profit for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $7.9 million.

  • Eton Pharmaceuticals' Gross Profit rose 2464.3% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year increase of 7561.88%. This contributed to the annual value of $23.4 million for FY2024, which is 1115.81% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Gross Profit of $7.9 million as of Q3 2025, which was up 2464.3% from $11.9 million recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Gross Profit peaked at $11.9 million during Q2 2025, and registered a low of $121000.0 during Q3 2021.
  • Over the past 5 years, Eton Pharmaceuticals' median Gross Profit value was $5.6 million (recorded in 2024), while the average stood at $5.7 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 34366666.67% in 2021, then plummeted by 8712.53% in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Gross Profit (Quarter) stood at $5.7 million in 2021, then grew by 11.17% to $6.4 million in 2022, then crashed by 42.92% to $3.6 million in 2023, then skyrocketed by 78.4% to $6.5 million in 2024, then rose by 21.29% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q3 2025, $11.9 million for Q2 2025, and $9.9 million during Q1 2025.